Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer. Chen DC, AlSaffar H, Graefen H, Perera S, et al. Eur Urol 2024;86:282-283.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen DC, AlSaffar H, Graefen H, Perera S, et al. Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer. Eur Urol 2024;86:282-283.
PMID: 38631993